Article Text

Download PDFPDF
Early response to treatment predicts remission and recovery at 3 years in people with schizophrenia

Statistics from


  • Source of funding: Eli Lilly Company, Germany


  • Competing interests: RE has participated in speakers/advisory boards and received honoraria from AstraZeneca, Bristol-Myers Squibb, Janssen, Lundbeck, Organon, Pfizer, Servier and Wyeth. He has received research funding from Janssen, Lundbeck and AstraZeneca.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.